Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bioatla, BMS, Mannkind.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agenus, Bioversys, Index, GSK, Ligand, Reneo, Ultimovacs.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Asclepix, Biomarin, Boehringer, Edgewise, Eyepoint, Ferring, Glycomimetics, Impact, Inmagene, Janssen, Johnson & Johnson, Kiora, Lineage, Lyra, Mind Medicine, Roche, Urogen.